First Cited
Last Cited

Articles citing This Document (Page 1 of 5)

A Review of Tisotumab Vedotin-tftv in Recurrent or Metastatic Cervical Cancer
Cost-effectiveness analysis of olanzapine in four-drug antiemetic therapy in Japanese patients treated with highly emetogenic cisplatin-containing chemotherapyJournal of Pharmaceutical Health Care and Sciences2022
New and emerging therapies for the treatment of relapsed/refractory diffuse large B-cell lymphoma.Journal of Oncology Pharmacy Practice2022
Prevention of Chemotherapy-Induced Nausea and Vomiting in the Older Patient: Optimizing OutcomesDrugs and Aging2021
Certified nurse specialists in cancer nursing and prophylactic antiemetic prescription for chemotherapy patients.Supportive Care in Cancer2022
Opportunities for personalizing colorectal cancer care: an analysis of SEER-medicare data.Pharmacogenomics Journal2022
Impact of reducing day 1 dexamethasone dose in anthracycline-containing regimens on acute gastrointestinal symptoms associated with breast cancer treatmentScientific Reports2021
A pooled analysis of adding olanzapine to guideline-recommended antiemetic therapy for breast cancer patients treated with an anthracycline and cyclophosphamide in prospective and retrospective studiesSupportive Care in Cancer2021
Chemotherapy and Prostate Cancer2021
5HT RA plus dexamethasone plus aprepitant for controlling delayed chemotherapy-induced nausea and vomiting in colorectal cancerCancer Science2021
Kanser Hastalarında Görülen Bulantı ve Kusma Semptomlarının YönetimiNevşehir Bilim Ve Teknoloji Dergisi
Chemotherapy Induced Nausea and Vomiting2019
Gastrointestinal Complications2019
Evaluation of Antiemetic Therapy for Breakthrough Nausea and Vomiting in Patients with Hematopoietic Stem Cell TransplantationKorean Journal of Clinical Pharmacy2018
A Pharmaco-Cybernetics Approach to Patient Safety2017
Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting2016
A Pharmaco-Cybernetics Approach to Patient Safety2016
Clinical Management of CINV2016
Delayed Nausea/Emesis2016
Nausea and VomitingPediatric Oncology2015
A Pharmaco-Cybernetics Approach to Patient SafetyAdvances in Healthcare Information Systems and Administration Book Series2014
Palliative Care for Cancer Patients and their Families
Management of Chemotherapy Induced Nausea and VomitingKorean Journal of Medicine2012
[Experience with aprepitant in the prevention of nausea and vomiting caused by highly emetic chemotherapy of lung cancer]2008
[Treatment of tumor therapy-induced nausea and vomiting]2009
Guideline-Recommended Symptom Management Strategies That Cross Over Two or More Cancer SymptomsOncology Nursing Forum2020
Intergenerational comparison of 5-HTRA in the prevention of chemotherapy-induced nausea and vomiting in gastric cancer patients receiving cisplatin-based chemotherapy: an observational study using a Japanese administrative claims databaseSupportive Care in Cancer2021
A phase 1 pharmacokinetic study of oral NEPA, the fixed combination of netupitant and palonosetron, in Chinese healthy volunteersCancer Chemotherapy and Pharmacology2021
Trastuzumab deruxtecan and other HER2-targeting agents for the treatment of HER2-positive gastric cancerExpert Review of Anticancer Therapy2021
Single-dose netupitant/palonosetron versus 3-day aprepitant for preventing chemotherapy-induced nausea and vomiting: a pooled analysisFuture Oncology2021
Chimeric Antigen Receptor T Cell Therapy: A Comprehensive Review of Clinical Efficacy, Toxicity, and Best Practices for Outpatient AdministrationTransplantation and Cellular Therapy2021
Efficacy and safety of 5 mg olanzapine for nausea and vomiting management in cancer patients receiving carboplatin: integrated study of three prospective multicenter phase II trialsBMC Cancer2021
Stability of Aprepitant Injectable Emulsion in Alternate Infusion Bags, in Refrigerated Storage, and Admixed with Dexamethasone and PalonosetronDrug Design, Development and Therapy2021
Real-world emetic risk of chemotherapy and the corresponding antiemetic therapy in Japan: A study based on a nationwide databaseCancer Reports2021
Effectiveness of palonosetron versus granisetron in preventing chemotherapy-induced nausea and vomiting: a systematic review and meta-analysisEuropean Journal of Clinical Pharmacology2021
Discovery and development of trastuzumab deruxtecan and safety management for patients with HER2-positive gastric cancerGastric Cancer2021
Effect of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Women: A Randomized Clinical TrialJAMA Network Open2021
Patient-perceived symptomatic benefits of olanzapine treatment for nausea and vomiting in patients with advanced cancer who received palliative care through consultation teams: a multicenter prospective observational studySupportive Care in Cancer2021
Treatment of Metastatic Gastrointestinal Stromal Tumors (GIST): A Focus on Older PatientsDrugs and Aging2021
The efficacy of aprepitant in salvage treatment of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy for patients with gastrointestinal cancerInternational Journal of Clinical Oncology2021
Antiemetic Efficacy of Adding Olanzapine 5 mg to Aprepitant, Palonosetron and Dexamethasone-Sparing After Day Two for Cancer Patients Receiving Anthracycline and CyclophosphamideCancer Management and Research2021
Glycemic Control as an Early Prognostic Marker in Advanced Pancreatic CancerFrontiers in Oncology2021
Efficacy of one-day versus multiple-day dexamethasone for chemotherapy-induced nausea and vomiting in lung cancer patients receiving carboplatin-based chemotherapy: a propensity score-matched analysisSupportive Care in Cancer2021
Efficacy of intravenous NEPA, a fixed NK/5-HT receptor antagonist combination, for the prevention of chemotherapy-induced nausea and vomiting (CINV) during cisplatin- and anthracycline cyclophosphamide (AC)-based chemotherapy: A review of phase 3 studiesCritical Reviews in Oncology/Hematology2021
A phase III study of transdermal granisetron versus oral ondansetron for women with gynecologic cancers receiving pelvic chemoradiationSupportive Care in Cancer2021
Pharmacists' Role in Managing Patients with Chronic Lymphocytic LeukemiaPharmacy (Basel, Switzerland)2020
Patient-Related Risk Factors for Chemotherapy-Induced Nausea and Vomiting: A Systematic ReviewFrontiers in Pharmacology2020
Expert Consensus on Effective Management of Chemotherapy-Induced Nausea and Vomiting: An Indian PerspectiveFrontiers in Oncology2020
Manage wisely: poly (ADP-ribose) polymerase inhibitor (PARPi) treatment and adverse eventsInternational Journal of Gynecological Cancer2020